Skip to content
The Nexus
DossierENTITY

right to try

Coverage of right to try in the Nexus archive.

Earliest in view: Jun 1 · 12:00 UTCMost recent: Jun 1 · 12:00 UTC
Co-mentioned in this coverage
Tomas Philipsonperson1FDAorganization1The Multi-Trillion Dollar Opportunity in Reforming the FDAtopic1Chinaplace1Operation Warp Speedtopic1artificial intelligencetopic1
Recent coverage
  • HEALTHJun 1 · 12:00 UTCFOX NEWS POLITICS
    FDA delays cost Americans trillions and slow lifesaving drugs, new report says

    A new report claims that accelerating FDA drug approvals could generate over $10 trillion in economic value by reducing delays in effectiveness trials, which currently take about a decade. The report suggests reforms like AI in reviews and faster trials to boost competition and lower drug costs, while also addressing China's competitive threat in clinical trials.